Aromatase Inhibitor News and Research

RSS
Aromatase Inhibitors are drugs that prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy for postmenopausal women who have hormone-dependent breast cancer.
Aspirin used in “baby” doses may prevent breast cancer, study suggests

Aspirin used in “baby” doses may prevent breast cancer, study suggests

Researchers find link between hormones and inguinal hernias in older men

Researchers find link between hormones and inguinal hernias in older men

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Aromatase inhibitors show advantages over tamoxifen in early-stage breast cancer

Aromatase inhibitors show advantages over tamoxifen in early-stage breast cancer

Estrogen receptor degrader increases progression-free survival in advanced breast cancer patients

Estrogen receptor degrader increases progression-free survival in advanced breast cancer patients

Pretreatment smoking linked to poor prognosis in AI-treated patients

Pretreatment smoking linked to poor prognosis in AI-treated patients

Investigational drug abemaciclib shows durable clinical activity for variety of cancer types

Investigational drug abemaciclib shows durable clinical activity for variety of cancer types

Estrogen-inhibiting drug may suppress dangerous brain seizures

Estrogen-inhibiting drug may suppress dangerous brain seizures

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

New MSK-led studies on liquid biopsy presented at San Antonio Breast Cancer Symposium

New MSK-led studies on liquid biopsy presented at San Antonio Breast Cancer Symposium

Monoclonal antibody reduces relapse rate by 18% in postmenopausal, HR-positive breast cancer patients

Monoclonal antibody reduces relapse rate by 18% in postmenopausal, HR-positive breast cancer patients

Adjuvant denosumab improves disease-free survival for postmenopausal women with early-stage, HR+ breast cancer

Adjuvant denosumab improves disease-free survival for postmenopausal women with early-stage, HR+ breast cancer

FDA grants Breakthrough Therapy Designation to Lilly's abemaciclib for treatment of metastatic breast cancer

FDA grants Breakthrough Therapy Designation to Lilly's abemaciclib for treatment of metastatic breast cancer

Study explores effectiveness of frontline treatments for couples with unexplained infertility

Study explores effectiveness of frontline treatments for couples with unexplained infertility

Study reveals molecular basis for endocrine therapy-resistant breast cancer

Study reveals molecular basis for endocrine therapy-resistant breast cancer

Noninvasive nuclear medicine test can help determine effectiveness of aromatase inhibitor treatment

Noninvasive nuclear medicine test can help determine effectiveness of aromatase inhibitor treatment

Scientists report that enzyme that alters testosterone to estrogen has big impact in healthy, injured brain

Scientists report that enzyme that alters testosterone to estrogen has big impact in healthy, injured brain

Letrozole helps restore fertility in obese, infertile men

Letrozole helps restore fertility in obese, infertile men

Preventive effect of tamoxifen drug for breast cancer remains virtually constant for 20 years

Preventive effect of tamoxifen drug for breast cancer remains virtually constant for 20 years

Drugs delay disease progression for women with hormone-receptor-positive metastatic breast cancer

Drugs delay disease progression for women with hormone-receptor-positive metastatic breast cancer